ChiCTR2500099478 版本V1.0 版本创建时间2025/03/24 18:16:31 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500099478 

最近更新日期:

Date of Last Refreshed on:

2025-03-24 18:16:13 

注册时间:

Date of Registration:

2025-03-24 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

指总伸肌劈开入路联合埋头加压空心钉治疗MasonII型和III型桡骨头骨折的疗效分析

Public title:

Analysis of extensor digitorum communis splitting approach combined with internal fixation of countersunk compression cannulated screw in the treatment of Mason II and Mason III radial head fractures

注册题目简写:

English Acronym:

研究课题的正式科学名称:

指总伸肌劈开入路联合埋头加压空心钉治疗MasonII型和III型桡骨头骨折的疗效分析

Scientific title:

Analysis of extensor digitorum communis splitting approach combined with internal fixation of countersunk compression cannulated screw in the treatment of Mason II and Mason III radial head fractures

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张博闻 

研究负责人:

刘波 

Applicant:

Bowen Zhang 

Study leader:

Bo Liu 

申请注册联系人电话:

Applicant telephone:

+86 182 2585 0515

研究负责人电话:

Study leader's
telephone:

+86 180 1099 8811

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zbw1845011146@163.com

研究负责人电子邮件:

Study leader's E-mail:

18010998811@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

安徽省阜阳市颍州区颍河西路1088号

研究负责人通讯地址:

安徽省阜阳市颍州区颍河西路1088号

Applicant address:

No.1088, Yinghe West road, Yingzhou District, Fuyang City, Anhui Prov.

Study leader's address:

No.1088, Yinghe West road, Yingzhou District, Fuyang City, Anhui Prov.

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

阜阳市第二人民医院

Applicant's institution:

No 2 People's Hospital of Fuyang City

研究负责人所在单位:

阜阳市第二人民医院

Affiliation of the Leader:

No 2 People's Hospital of Fuyang City

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

20241210073

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

阜阳市第二人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Second People's Hospital of Fuyang

伦理委员会批准日期:

Date of approved by ethic committee:

2024-12-10 00:00:00

伦理委员会联系人:

刘军

Contact Name of the ethic committee:

Jun Liu

伦理委员会联系地址:

安徽省阜阳市颍河西路1088号

Contact Address of the ethic committee:

1088 Yinghe West Road, Fuyang City, Anhui Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 173 5586 6020

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

阜阳市第二人民医院

Primary sponsor:

No 2 People's Hospital of Fuyang City

研究实施负责(组长)单位地址:

安徽省阜阳市颍州区颍河西路1088号

Primary sponsor's address:

No.1088, Yinghe West road, Yingzhou District, Fuyang City, Anhui Prov.

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽

市(区县):

阜阳

Country:

China

Province:

Anhui

City:

Fuyang

单位(医院):

阜阳市第二人民医院

具体地址:

安徽省阜阳市颍州区颍河西路1088号

Institution
hospital:

No 2 People's Hospital of Fuyang City

Address:

No.1088, Yinghe West road, Yingzhou District, Fuyang City, Anhui Prov.

经费或物资来源:

自筹

Source(s) of funding:

self-raised

研究疾病:

桡骨头骨折  

Target disease:

radial head fractures

研究疾病代码:

Target disease code:

研究类型:

治疗研究

Study type:

Treatment study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

分析指总伸肌劈开入路联合埋头加压空心钉治疗MasonII型和III型桡骨头骨折的疗效  

Objectives of Study:

This study aimed to investigate the clinical effect of the EDC splitting approach combined with the internal fixation of countersunk compression cannulated screw in the therapy of Mason II and Mason III radial head fractures.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

患者年龄大于18岁;MasonII型或MasonIII型骨折;经EDC劈开入路联合埋头加压空心螺钉固定;随访资料完整

Inclusion criteria

patients older than 18 years old; Mason II or Mason III fractures; ORIF was performed via EDC splitting approach combined with countersunk compression cannulated screws; follow-up data were complete.

排除标准:

术前合并血管神经损伤;术前合并韧带损伤,肘关节不稳;过于粉碎无法固定的MasonIII型骨折;陈旧性骨折。开放性骨折

Exclusion criteria:

preoperative vascular and nerve injury; preoperative combined ligament injury, elbow instability; Mason III fractures too comminuted to be fixed; old fracture.open fracture

研究实施时间:

Study execute time:

From 2020-08-01 00:00:00 To 2024-12-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-12-11 00:00:00 To 2024-12-30 00:00:00

干预措施:

Interventions:

组别:

手术组

样本量:

26

Group:

Operation group

Sample size:

干预措施:

手术

干预措施代码:

Intervention:

Operation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽 

市(区县):

阜阳 

Country:

China

Province:

Anhui

City:

Fuyang

单位(医院):

阜阳市第二人民医院 

单位级别:

三甲 

Institution
hospital:

No 2 People's Hospital of Fuyang City

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肘关节活动角度

指标类型:

主要指标

Outcome:

Elbow joint movement Angle

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肘关节肌力

指标类型:

主要指标

Outcome:

Elbow joint muscle strength

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Mayo肘关节功能评分

指标类型:

主要指标

Outcome:

Mayo elbow joint function score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Broberg和Morrey等级系统

指标类型:

主要指标

Outcome:

Broberg and Morrey rating system

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

并发症

指标类型:

次要指标

Outcome:

Complications

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

主观满意度

指标类型:

次要指标

Outcome:

Subjective satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

日期:2025年7月 方式:百度网盘 链接:https://pan.baidu.com/doc/share/R11ZSk4l4e4y6RQW8wTnuQ-24688956576788

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Date: July 2025 Method: Baidu network disk Website: https://pan.baidu.com/doc/share/R11ZSk4l4e4y6RQW8wTnuQ-24688956576788

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

未说明

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Not stated

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-03-24 18:16:13